BBC

Fund Description
Virtus LifeSci Biotech Clinical Trials ETF is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.
Fund Profile
Fund Name Virtus LifeSci Biotech Clinical Trials ETF
Fund Exchange Ticker BBC
Fund Sponsor Bioshares
Fund ISIN US26923G3011
Net Expense Ratio 0.79 %
Fund Inception Date 17 December 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name LifeSci Biotechnology Clinical Trials Index
Index Provider LifeSci Index Partners
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 August 2019
Asset Under Management 26.06 Million (USD)
1 Month Total Return -1.77 %
Year To Date Return 17.83 %
1 Year Total Return -14.77 %
3 Year Annualized Total Return 10.32 %
NAV 27.4298
Share Outstanding 950,004
Top 10 Holdings (21 August 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
G1 THERAPEUTICS INC GTHX EQUI 0.0216
ALLAKOS INC ALLK EQUI 0.0216
DECIPHERA PHARMACEUTICALS IN DCPH EQUI 0.0178
ACHILLION PHARMACEUTICALS ACHN EQUI 0.017
KARYOPHARM THERAPEUTICS INC KPTI EQUI 0.0167
KRYSTAL BIOTECH INC KRYS EQUI 0.0167
CYTOKINETICS INC CYTK EQUI 0.0149
EIDOS THERAPEUTICS INC EIDX EQUI 0.0148
AVROBIO INC AVRO EQUI 0.0147
Synthorx Inc THOR EQUI 0.0146